Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Jefferies Healthcare Conference June 7-8, 2023
MORRISTOWN, N.J., May 31, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it will be participating in investor meetings at the Jefferies Healthcare Conference at the Marriott Marquis in New York City on June 7-8, 2023.
Meeting Details?
For investors attending the conference who wish to meet with the Intercept management team, please reach out to Nareg Sagherian at Intercept to check the team’s availability.?
About Intercept??
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH) and severe alcohol-associated hepatitis (sAH). For more information, please visit?www.interceptpharma.com?or connect with the Company on Twitter and LinkedIn.??
Contact??
For more information about Intercept, please contact:??
Investor inquiries:?investors@interceptpharma.com??
Media inquiries:?media@interceptpharma.com??
Upcoming Life Sciences Events
- April 2024
- Basel: Swiss Biotech Day 2024
- London: BioTrinity 2024
- Singapore: Asia Bio Partnering Forum
Latest company news
Skye Bioscience to Present at Upcoming Investment Conferences